Advertisement

Oncological Outcomes

  • Filippo La TorreEmail author
  • Marco La Torre
Chapter
Part of the Updates in Surgery book series (UPDATESSURG)

Abstract

Pelvic recurrence of colorectal cancer (PRCRC) is a common problem after curative colorectal resection for colorectal adenocarcinoma, even in the neoadjuvant treatment age, with an incidence varying between 5% and 50% [1, 2]. Although there have been distinct improvements of therapeutic algorithms in managing systemic hepatic and pulmonary colorectal metastasis, there is no general acceptance of the same radical approach for isolated locally recurrent rectal cancer (LRRC) [3, 4]. In the absence of any treatment, survival of patients with PRCRC is poor and is associated with severe and unpleasant symptoms, such as pain, rectal bleeding, bowel or ureter occlusion, tenesmus, enterocutaneous fistulas, and ulcerating skin lesions [1]. Palliative radiotherapy (RT) alone or in combination with chemotherapy can achieve temporary symptomatic improvement in the majority of patients, but 5-year survival is usually <5% [5, 6]. Palliative surgery can prolong survival, but exposes the patient to substantial postoperative morbidity/mortality [5, 6]. Complete surgical resection with clear circumferential and distal margins (R0), in association with multimodal treatment (preoperative radiochemotherapy or intraoperative RT), remains the best option for cure after a PRCRC. The reported 5-year survival rates vary from 22 to 58% after obtaining R0 resection [7, 8, 9]. Therefore, it is essential to: (1) predict failure patterns, and (2) accurately stratify prognosis in relation to the different planned treatments so that appropriate therapy can be selected and proposed. This chapter discusses oncological outcomes of patients with PRCRC resulting from different treatment types.

Keywords

Overall Survival Multimodal Treatment Extended Resection Palliative Resection Pelvic Recurrence 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Pacelli F, Tortorelli AP, Rosa F et al (2010) Locally recurrent rectal cancer: prognostic factors and long-term outcomes of multimodal therapy. Ann Surg Oncol 17:152–162CrossRefPubMedGoogle Scholar
  2. 2.
    Caricato M, Borzomati D, Ausania F et al (2006) Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 32:126–132CrossRefPubMedGoogle Scholar
  3. 3.
    Hahnloser D, Nelson H, Gunderson LL et al (2003) Curative potential of multimodality therapy for locally recurrent rectal cancer. Ann Surg 237:502–508PubMedCentralPubMedGoogle Scholar
  4. 4.
    Hansen MH, Balteskard L, Dørum LM et al (2009) Norwegian Colorectal Cancer Group. Locally recurrent rectal cancer in Norway. Br J Surg 96:1176–1182CrossRefPubMedGoogle Scholar
  5. 5.
    Hashiguchi Y, Sekine T, Sakamoto H et al (1999) Intraoperative irradiation after surgery for locally recurrent rectal cancer. Dis Colon Rectum 42:886–893CrossRefPubMedGoogle Scholar
  6. 6.
    Bae SH, Park W, Choi DH et al (2011) Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer. Radiat Oncol 6:52PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Bhangu A, Ali SM, Cunningham D et al (2013) Comparison of long-term survival outcome of operative vs nonoperative management of recurrent rectal cancer. Colorectal Dis 15:156–163CrossRefPubMedGoogle Scholar
  8. 8.
    Haddock MG, Miller RC, Nelson H et al (2011) Combined modality therapy including intraoperative electron irradiation for locally recurrent colorectal cancer. Int J Radiat Oncol Biol Phys 79:143–150CrossRefPubMedGoogle Scholar
  9. 9.
    Larsen SG, Wiig JN, Tretli S et al (2006) Surgery and pre-operative irradiation for locally advanced or recurrent rectal cancer in patients over 75 years of age. Colorectal Dis 8:177–185CrossRefPubMedGoogle Scholar
  10. 10.
    Willett CG, Gunderson LL (2004) Palliative treatment of rectal cancer: is radiotherapy alone a good option? J Gastrointest Surg 8:277-279CrossRefPubMedGoogle Scholar
  11. 11.
    Lybeert MLM, Martijn H, DeNeve W et al (1992) Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence of relapse free survival and survival. Int J Radiat Oncol Biol Phys 24:241–246CrossRefPubMedGoogle Scholar
  12. 12.
    Guiney MJ, Smith JG, Worotniuk V et al (1997) Radiotherapy treatment for isolated locoregional recurrence of rectosigmoid cancer following definitive surgery: Peter MacCullum Cancer Institute experience, 1981–1990. Int J Radiat Oncol Biol Phys 38:1019–1025CrossRefPubMedGoogle Scholar
  13. 13.
    Garcia-Aguilar J, Cromwell JW, Marra C et al (2001) Treatment of locally recurrent rectal cancer. Dis Colon Rectum 44:1743–1748CrossRefPubMedGoogle Scholar
  14. 14.
    Asoglu O, Karanlik H, Muslumanoglu M et al (2007) Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 33:1199–1206CrossRefPubMedGoogle Scholar
  15. 15.
    Yamada K, Ishizawa T, Niwa K et al (2001) Patterns of pelvic invasion are prognostic in the treatment of locally recurrent rectal cancer. Br J Surg 88:988–993CrossRefPubMedGoogle Scholar
  16. 16.
    Kanemitsu Y, Hirai T, Komori K et al (2010) Prediction of residual disease or distant metastasis after resection of locally recurrent rectal cancer. Dis Colon Rectum 53:779–789CrossRefPubMedGoogle Scholar
  17. 17.
    Vermaas M, Ferenschild FT, Nuyttens JJ et al (2005) Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 48:918–928CrossRefPubMedGoogle Scholar
  18. 18.
    Weiser MR, Landmann RG, Wong WD et al (2005) Surgical salvage of recurrent rectal cancer after transanal excision. Dis Colon Rectum 48:1169–1175CrossRefPubMedGoogle Scholar
  19. 19.
    Kakuda JT, Lamont JP, Chu DZ et al (2003) The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 186:660–664CrossRefPubMedGoogle Scholar
  20. 20.
    You YN, Habiba H, Chang GJ et al (2011) Prognostic value of quality of life and pain in patients with locally recurrent rectal cancer. Ann Surg Oncol 18:989–996PubMedCentralCrossRefPubMedGoogle Scholar
  21. 21.
    Dresen RC, Gosens MJ, Martijn H et al (2008) Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 15:1937–1947PubMedCentralCrossRefPubMedGoogle Scholar
  22. 22.
    Gagliardi G, Hawley PR, Hershman MJ et al (1995) Prognostic factors in surgery for local recurrence of rectal cancer. Br J Surg 82:1401–1405CrossRefPubMedGoogle Scholar
  23. 23.
    Shoup M, Guillem JG, Alektiar KM et al (2002) Predictors of survival in recurrent rectal cancer after resection and intraoperative radiotherapy. Dis Colon Rectum 45:585–592CrossRefPubMedGoogle Scholar
  24. 24.
    Lopez-Kostner F, Fazio VW, Vignali A et al (2001) Locally recurrent rectal cancer: predictors and success of salvage surgery. Dis Colon Rectum 44:173–178CrossRefPubMedGoogle Scholar
  25. 25.
    Rödel C, Grabenbauer GG, Matzel KE et al (2000) Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 43:312–319CrossRefPubMedGoogle Scholar
  26. 26.
    Maetani S, Onodera H, Nishikawa T (2007) Long-term cure in surgery for extrarectal pelvic recurrence of rectal cancer. Dis Colon Rectum 50:1558–1565CrossRefPubMedGoogle Scholar
  27. 27.
    Melton GB, Paty PB, Boland PJ et al (2006) Sacral resection for recurrent rectal cancer: analysis of morbidity and treatment results. Dis Colon Rectum 49:1099–1107CrossRefPubMedGoogle Scholar
  28. 28.
    Kusters M, Dresen RC, Martijn H et al (2009) Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer. Int J Radiat Oncol Biol Phys 75:1444–1449CrossRefPubMedGoogle Scholar
  29. 29.
    Sagar PM, Gonsalves S, Heath RM et al (2009) Composite abdominosacral resection for recurrent rectal cancer. Br J Surg 96:191–196CrossRefPubMedGoogle Scholar
  30. 30.
    Reerink O, Mulder NH, Botke G et al (2004) Treatment of locally recurrent rectal cancer, results and prognostic factors. Eur J Surg Oncol 30:954–958CrossRefPubMedGoogle Scholar
  31. 31.
    Rahbari NN, Ulrich AB, Bruckner T et al (2011) Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure? Ann Surg 253:522–533CrossRefPubMedGoogle Scholar
  32. 32.
    Bedrosian I, Giacco G, Pederson L et al (2006) Outcome after curative resection for locally recurrent rectal cancer. Dis Colon Rectum 49:175–182CrossRefPubMedGoogle Scholar
  33. 33.
    Heriot AG, Byrne CM, Lee P et al (2008) Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 51:284–291CrossRefPubMedGoogle Scholar
  34. 34.
    Saito N, Koda K, Takiguchi N et al (2003) Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 20:192–199CrossRefPubMedGoogle Scholar
  35. 35.
    Boyle KM, Sagar PM, Chalmers AG et al (2005) Surgery for locally recurrent rectal cancer. Dis Colon Rectum 48:929–937CrossRefPubMedGoogle Scholar
  36. 36.
    Valentini V, Morganti AG, Gambacorta MA et al (2006) Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys 64:1129–1139CrossRefPubMedGoogle Scholar
  37. 37.
    Mohiuddin M, Marks G, Marks J (2002) Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 95:1144–1150CrossRefPubMedGoogle Scholar
  38. 38.
    Wells BJ, Stotland P, Ko MA et al (2007) Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 14:390–395CrossRefPubMedGoogle Scholar
  39. 39.
    Takagi H, Morimoto T, Hara S et al (1986) Seven cases of pelvic exenteration combined with sacral resection for locally recurrent rectal cancer. J Surg Oncol 32:184–188CrossRefPubMedGoogle Scholar
  40. 40.
    Pearlman NW, Donohue RE, Stiegmann GV et al (1987) Pelvic and sacropelvic exenteration for locally advanced or recurrent anorectal cancer. Arch Surg 122:537–541CrossRefPubMedGoogle Scholar
  41. 41.
    Moriya Y, Akasu T, Fujita S et al (2004) Total pelvic exenteration with distal sacrectomy for fixed recurrent rectal cancer in the pelvis. Dis Colon Rectum 47:2047–2053CrossRefPubMedGoogle Scholar
  42. 42.
    Lindel K, Willett CG, Shellito PC et al (2001) Intraoperative radiation therapy for locally advanced recurrent rectal or rectosigmoid cancer. Radiother Oncol 58:83–87CrossRefPubMedGoogle Scholar
  43. 43.
    Mannaerts GH, Rutten HJ, Martijn H et al (2001) Comparison of intraoperative radiation therapy-containing multimodality treatment with historical treatment modalities for locally recurrent rectal cancer. Dis Colon Rectum 44:1749–1758CrossRefPubMedGoogle Scholar
  44. 44.
    Mercantini P, Di Somma S, Magrini L et al (2012) Preoperative brain natriuretic peptide (BNP) is a better predictor of adverse cardiac events compared to preoperative scoring system in patients who underwent abdominal surgery. World J Surg 36:24–30CrossRefPubMedGoogle Scholar
  45. 45.
    Wiig JN, Tveit KM, Poulsen JP et al (2002) Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 62:207–213CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2016

Authors and Affiliations

  1. 1.Emergency Department, 3rd Department of SurgeryPoliclinico Umberto I, Sapienza University HospitalRomeItaly

Personalised recommendations